Fortunato Bianconi
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Global Cancer Incidence and Screening, Gene Regulatory Network Analysis, Bioinformatics and Genomic Networks, Colorectal Cancer Screening and Detection
Most-Cited Works
- → Phosphoinositide-3-Kinase Catalytic Alpha and KRAS Mutations are Important Predictors of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Advanced Non-small Cell Lung Cancer(2011)176 cited
- → High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients(2009)114 cited
- → Computational model of EGFR and IGF1R pathways in lung cancer: A Systems Biology approach for Translational Oncology(2011)47 cited
- → Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications(2018)43 cited
- → Gene identification for risk of relapse in stage I lung adenocarcinoma patients: a combined methodology of gene expression profiling and computational gene network analysis(2016)40 cited
- → Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations(2012)39 cited
- → Linking surgical specimen length and examined lymph nodes in colorectal cancer patients(2015)35 cited
- → Information Technology as Tools for Cancer Registry and Regional Cancer Network Integration(2012)31 cited
- → High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients(2021)27 cited
- → MYC and Human Telomerase Gene (TERC) Copy Number Gain in Early-stage Non–small Cell Lung Cancer(2013)24 cited